Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-92
4-Aminobenzamidine Dihydrochloride
Cat. No.
AKA-92
CAS No.
2498-50-2
MF
C7H11Cl2N3
MW
208.09
4-Aminobenzamidine Dihydrochloride is an important intermediate of Dabigatran etexilate.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
4-Aminobenzamidine Dihydrochloride
CAS No.
2498-50-2
MF
C7H11Cl2N3
MW
208.09
Specification
98%
Description
4-Aminobenzamidine Dihydrochloride is an important intermediate of Dabigatran etexilate. Packing: 1kg/bag; 25kg/drum or as request
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Nguyen AL, et al. The development and application of a new affinity partitioning system for enzyme isolation and purification. Enzyme and Microbial Technology. 1990 Sep;12(9):663-8.
[2]. Billström A, et al. The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice. International Journal of Cancer. 1995 May 16;61(4):542-7.
[3]. Okumura N, et al. Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism. Bioscience, Biotechnology, and Biochemistry. 2007 Jun;71(6):1542-9.
[4]. Dutra JBR, et al. p-Aminobenzamidine attenuates cardiovascular dysfunctions in spontaneously hypertensive rats. Life Sciences. 2022 Sep 1;304:120693.
[2]. Billström A, et al. The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice. International Journal of Cancer. 1995 May 16;61(4):542-7.
[3]. Okumura N, et al. Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism. Bioscience, Biotechnology, and Biochemistry. 2007 Jun;71(6):1542-9.
[4]. Dutra JBR, et al. p-Aminobenzamidine attenuates cardiovascular dysfunctions in spontaneously hypertensive rats. Life Sciences. 2022 Sep 1;304:120693.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
AKA-373
Abietic acid
CAS No.:514-10-3
MF:C20H30O2
AKA-372
Dipexion™ Fmoc-Val-Ser(psi(Me,Me)pro)-OH
CAS No.:186023-49-4
MF:C26H30N2O6
AKA-371
Dipexion™ Fmoc-Gly-Ser(psi(Me,Me)pro)-OH
CAS No.:1095952-22-9
MF:C23H24N2O6
AKA-370
Oxymatrine
CAS No.:16837-52-8
MF:C15H24N2O2
AKA-369
Matrine
CAS No.:519-02-8
MF:C15H24N2O
AKA-368
Dipexion™ Fmoc-Lys（Boc）-Thr[PSI(Me,Me)Pro]-OH
CAS No.:911838-56-7
MF:C33H43N3O8
AKA-367
Dipexion™ Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH
CAS No.:339531-50-9
MF:C27H32N2O6
AKA-366
Dipexion™ Fmoc-Ser(tBu)-Thr[PSI(Me,Me)Pro]-OH
CAS No.:1266350-99-5
MF:C29H36N2O7
AKA-365
Dipexion™ Fmoc-Glu(OtBu)-Thr[PSI(Me,Me)Pro]-OH
CAS No.:957780-56-2
MF:C31H38N2O8
AKA-364
Dipexion™ Fmoc-Lys（Boc）-Ser[PSI(Me,Me)Pro]-OH
CAS No.:957780-54-0
MF:C32H41N3O8
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
